A clinical trial set to start this month will modify ovarian cancer cells and return them to patients to stimulate an immune ...

Uvalde school officer Adrian Gonzales, who was indicted in 2024 on child endangerment and abandonment charges, will go to ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

A 2022 study estimates that at-home flu tests have a sensitivity of about 61% if the test is performed within 72 hours of ...

Dr. Gil Mor discusses sex-specific placental responses and long-term immune alterations from prenatal virus exposure.

During his public inauguration ceremony at New York City Hall on New Year's Day, Mamdani was sworn in by Vermont Sen. Bernie ...

The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...

Sequential BCL2 inhibitor therapy shows initial responses but lacks durability, especially in patients exposed to both BTKi ...

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

Lynozyfic (linvoseltamab), a B-cell maturation antigen and CD3 bispecific antibody, showed a high overall response rate and a ...

Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.